Palatin Technologies (PTN) Asset Utilization Ratio (2011 - 2026)
Palatin Technologies' (PTN) quarterly Asset Utilization Ratio came in at 0.83 in Q1 2026, up 848.58% on a YoY basis from 0.09 in Q1 2025, and up 22.54% quarter-over-quarter from 0.67 in Q4 2025.
Analysis
Palatin Technologies (PTN) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Palatin Technologies (PTN) has reported Asset Utilization Ratio for 13 consecutive years, with 0.83 the latest figure, recorded in Q1 2026.
- For the quarter ending Q1 2026, Asset Utilization Ratio rose 848.58% year-over-year to 0.83; the trailing twelve-month figure through Mar 2026 stood at 0.83 (up 848.58% YoY), and the FY2024 full-year result was 0.31, up 74.2% from the prior year.
- Asset Utilization Ratio improved to 0.83 in Q1 2026 per PTN's latest filing, from 0.67 in the prior quarter.
- Across five years, Asset Utilization Ratio topped out at 1.49 in Q3 2025 and bottomed at 0.01 in Q1 2022.
- Historically, Asset Utilization Ratio has averaged 0.37 across 5 years, with a median of 0.28 in 2024.
- The sharpest annual moves came in 2022 and 2024: Asset Utilization Ratio jumped 1209.57% in 2022, then slumped 84.17% in 2024.
- Over 5 years, Asset Utilization Ratio stood at 0.1 in 2022, then soared by 491.8% to 0.57 in 2023, then plunged by 84.17% to 0.09 in 2024, then surged by 643.94% to 0.67 in 2025, then climbed by 22.54% to 0.83 in 2026.
- According to Business Quant data, Asset Utilization Ratio over the past three periods registered 0.83, 0.67, and 1.49 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 0.40 |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 0.58 |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 0.47 |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 0.38 |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 0.20 |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 0.90 |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 0.33 |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 0.00 |
| 10 | Palatin Technologies | 46.98 Mn | 46.98 Mn | - | 0.83 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 0.83 |
| Dec 31, 2025 | 0.67 |
| Sep 30, 2025 | 1.49 |
| Mar 31, 2025 | 0.09 |
| Dec 31, 2024 | 0.09 |
| Sep 30, 2024 | 0.34 |
| Jun 30, 2024 | 0.41 |
| Mar 31, 2024 | 0.47 |
| Dec 31, 2023 | 0.57 |
| Sep 30, 2023 | 0.42 |
| Jun 30, 2023 | 0.22 |
| Mar 31, 2023 | 0.13 |
| Dec 31, 2022 | 0.10 |
| Sep 30, 2022 | 0.07 |
| Jun 30, 2022 | 0.04 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.01 |
| Sep 30, 2021 | 0.01 |
| Jun 30, 2021 | 0.01 |
| Mar 31, 2021 | 0.01 |